Rheumatology Network's Top 5: March 5, 2021
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending March 5, 2021.
Rheumatology 2021: Quo Vadis? Part II
In the second portion of this series, Dr. Concoff discusses the path forward in the evaluation and treatment of systemic lupus erythematosus (SLE).
Click the image to view this story.
.png?w=1500&fit=max&auto=format)
Patients With Rheumatoid Arthritis Are Wary of Prednisolone Usage
Patients with rheumatoid arthritis (RA) believe that prednisolone is a necessary medication, yet they are cautious about taking it due to the adverse effects, according to a new study.
Click the image to view this story.
Patients With Rheumatoid Arthritis Have an Increased Risk of Multimorbidity Burden
Investigators believe inflammation, which is known to begin before rheumatoid arthritis (RA) symptoms appear, may be a main factor in the increased prevalence and incidence in multimorbidity for patients with RA.
Click the image to view this story.
The Secret to Quality Doctor-Patient Relationships
Readers may be surprised to hear that a high percentage of health professionals, about 70%, find it difficult to develop empathy with their patients.
Click the image to view this story.
Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus
Brian Skaggs, PhD, and Maureen McMahon, MD, sat down with Rheumatology Network to discuss the results of their longitudinal study, “A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus.”
Click the image to view this story.
